Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte C Widemann

Showing results (11-20 of 203) with videos related to

Pageof 21
Sort By:
Journal of the National Cancer Institute|September 28, 2017
Editorial: US Cancer Statistics of Survival: Achievements, Challenges, and Future DirectionsShahinaz M Gadalla, Brigitte C Widemann
Neuro-Oncology Advances|July 10, 2020
Clinical trial design in neurofibromatosis type 1 as a model for other tumor predisposition syndromesAndrea M Gross, Brigitte C Widemann
The New England Journal of Medicine|March 23, 2017
Selumetinib in Plexiform NeurofibromasAndrea Gross, Rachel Bishop, Brigitte C Widemann
The Oncologist|August 4, 2009
Sorafenib and sunitinibAeRang Kim, Frank M Balis, Brigitte C Widemann
Current Problems in Cancer|July 16, 2021
Chordoma: Current status, problems, and future directionsMary Frances Wedekind, Brigitte C Widemann, Gregory Cote
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|July 2, 2020
Current status of MEK inhibitors in the treatment of plexiform neurofibromasAndrea M Gross, Eva Dombi, Brigitte C Widemann
Neurology|July 7, 2021
Neurofibromatosis Clinical Trials-REiNS Collaboration 2020 Recommendations: Looking Back and Moving AheadAndrea M Gross, Scott R Plotkin, Brigitte C Widemann, et al.
Contemporary Clinical Trials|October 19, 2010
Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer InstituteStaci Martin, Andrea Gillespie, Pamela L Wolters, et al.
Journal of Neuro-Oncology|October 9, 2014
Characterization of spinal findings in children and adults with neurofibromatosis type 1 enrolled in a natural history study using magnetic resonance imagingRosa Nguyen, Eva Dombi, Srivandana Akshintala, et al.
Psycho-Oncology|December 2, 2015
Validity, specificity, feasibility and acceptability of a brief pediatric distress thermometer in outpatient clinicsLori Wiener, Haven Battles, Sima Zadeh, et al.
Pageof 21

Showing results (11-20 of 203) with videos related to

Sort By:
Pageof 21
Journal of the National Cancer Institute|September 28, 2017
Editorial: US Cancer Statistics of Survival: Achievements, Challenges, and Future DirectionsShahinaz M Gadalla, Brigitte C Widemann
Neuro-Oncology Advances|July 10, 2020
Clinical trial design in neurofibromatosis type 1 as a model for other tumor predisposition syndromesAndrea M Gross, Brigitte C Widemann
The New England Journal of Medicine|March 23, 2017
Selumetinib in Plexiform NeurofibromasAndrea Gross, Rachel Bishop, Brigitte C Widemann
The Oncologist|August 4, 2009
Sorafenib and sunitinibAeRang Kim, Frank M Balis, Brigitte C Widemann
Current Problems in Cancer|July 16, 2021
Chordoma: Current status, problems, and future directionsMary Frances Wedekind, Brigitte C Widemann, Gregory Cote
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|July 2, 2020
Current status of MEK inhibitors in the treatment of plexiform neurofibromasAndrea M Gross, Eva Dombi, Brigitte C Widemann
Neurology|July 7, 2021
Neurofibromatosis Clinical Trials-REiNS Collaboration 2020 Recommendations: Looking Back and Moving AheadAndrea M Gross, Scott R Plotkin, Brigitte C Widemann, et al.
Contemporary Clinical Trials|October 19, 2010
Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer InstituteStaci Martin, Andrea Gillespie, Pamela L Wolters, et al.
Journal of Neuro-Oncology|October 9, 2014
Characterization of spinal findings in children and adults with neurofibromatosis type 1 enrolled in a natural history study using magnetic resonance imagingRosa Nguyen, Eva Dombi, Srivandana Akshintala, et al.
Psycho-Oncology|December 2, 2015
Validity, specificity, feasibility and acceptability of a brief pediatric distress thermometer in outpatient clinicsLori Wiener, Haven Battles, Sima Zadeh, et al.
Pageof 21